Linrodostat

DB14986InvestigationalSmall molecule

Linrodostat is under investigation in clinical trial NCT03247283 (Pharmacokinetics and Metabolism Study in Healthy Male Participants).

Mechanism: Pharmacologically active on Indoleamine 2,3-dioxygenase 1
Curator reviewed
Formula / weight: C₂₄H₂₄ClFN₂O · 410.92 g/mol (avg)
Code names: BMS-986205

Resolves to

Compound

Structure

InChIKeyKRTIYQIPSAGSBP-ZACQAIPSSA-NSMILES[H][C@@]1(CC[C@]([H])(CC1)C1=C2C=C(F)C=CC2=NC=C1)[C@@H](C)C(=O)NC1=CC=C(Cl)C=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

20Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Linrodostat, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.